Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GPR3 | P46089 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 2/20 | 0.33 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TYMS | P04818 | 2/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5510961 | 0.80 | KDM4E (0.44) | KDM4EGPR3NPC1LMNARAB9A | |
| SCHEMBL27501514 | 0.80 | KDM4E (0.57) | KDM4EGPR3NPC1LMNARAB9A | |
| SCHEMBL159416 | 0.79 | KDM4E (0.59) | KDM4EGPR3NPC1LMNARAB9A | |
| SCHEMBL31684807 | 0.79 | KDM4E (0.59) | KDM4EGPR3NPC1LMNARAB9A | |
| Water SCHEMBL28628706 | 0.79 | KDM4E (0.55) | KDM4EGPR3NPC1LMNARAB9A | |
| Hydrochloric Acid SCHEMBL9110426 | 0.77 | KDM4E (0.57) | KDM4EGPR3NPC1LMNARAB9A | |
| SCHEMBL5510958 | 0.75 | KDM4E (0.50) | KDM4EGPR3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL329200 | 0.73 | KDM4E (0.57) | KDM4EGPR3NPC1LMNARAB9A | |
| SCHEMBL29780666 | 0.73 | CYP3A4 (0.58) | KDM4EGPR3NPC1LMNARAB9A | |
| SCHEMBL10025808 | 0.72 | GPR3 (0.68) | KDM4EGPR3NPC1LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114685351-B | OLED main body material based on triptycene framework and preparation method and application thereof | 中国科学院化学研究所 | 2023-04-18 | — | — | CN | claimed |
| CN-114685351-A | OLED main body material based on triptycene framework and preparation method and application thereof | 中国科学院化学研究所 | 2022-07-01 | — | — | CN | claimed |
| CN-114685351-B | OLED main body material based on triptycene framework and preparation method and application thereof | 中国科学院化学研究所 | 2023-04-18 | — | — | CN | disclosed |
| CN-114685351-A | OLED main body material based on triptycene framework and preparation method and application thereof | 中国科学院化学研究所 | 2022-07-01 | — | — | CN | disclosed |
| CN-110256428-B | Compound, OLED display panel and display device | 上海天马有机发光显示技术有限公司 | 2021-04-13 | — | — | CN | disclosed |
| US-7651746-B2 | Halogenated bisdiarylaminopolycyclic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
| WO-2005049546-A1 | HALOGENATED BISDIARYLAMINOPOLYCYLIC AROMATIC COMPOUNDS AND POLYMERS THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | AHR, AADAC, ARNT | KDM4E 3463/4885GPR3 1136/4885NPC1 4137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.